Greenleaf Trust Sells 1,161 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Greenleaf Trust lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 20.1% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,610 shares of the company's stock after selling 1,161 shares during the quarter. Greenleaf Trust's holdings in HCA Healthcare were worth $1,593,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Norges Bank acquired a new position in HCA Healthcare during the fourth quarter worth about $840,286,000. GAMMA Investing LLC increased its stake in shares of HCA Healthcare by 40,527.3% in the first quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company's stock valued at $5,887,850,000 after buying an additional 1,699,713 shares during the period. Royal London Asset Management Ltd. increased its stake in shares of HCA Healthcare by 62.0% in the fourth quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company's stock valued at $450,461,000 after buying an additional 574,239 shares during the period. Barclays PLC increased its stake in shares of HCA Healthcare by 85.7% in the fourth quarter. Barclays PLC now owns 1,061,891 shares of the company's stock valued at $318,727,000 after buying an additional 489,916 shares during the period. Finally, Two Sigma Investments LP increased its stake in shares of HCA Healthcare by 12,016.0% in the fourth quarter. Two Sigma Investments LP now owns 467,437 shares of the company's stock valued at $140,301,000 after buying an additional 463,579 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.

Insider Buying and Selling at HCA Healthcare

In other news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the transaction, the chief operating officer owned 12,646 shares in the company, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.30% of the company's stock.

HCA Healthcare Stock Up 1.2%

NYSE HCA traded up $4.36 on Monday, reaching $380.43. The company had a trading volume of 932,188 shares, compared to its average volume of 1,458,219. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The stock has a market capitalization of $91.52 billion, a P/E ratio of 16.92, a P/E/G ratio of 1.30 and a beta of 1.47. The company's fifty day moving average is $375.13 and its 200 day moving average is $342.25. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.75 by $0.70. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The firm had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. During the same period last year, the firm posted $5.36 EPS. The business's revenue was up 5.7% compared to the same quarter last year. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Monday, June 16th were paid a dividend of $0.72 per share. The ex-dividend date was Monday, June 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.76%. HCA Healthcare's payout ratio is 12.81%.

Analysts Set New Price Targets

HCA has been the topic of several analyst reports. Baird R W cut HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Morgan Stanley set a $410.00 target price on HCA Healthcare and gave the company an "equal weight" rating in a report on Monday, June 9th. Royal Bank Of Canada reiterated an "outperform" rating and issued a $404.00 target price (up from $376.00) on shares of HCA Healthcare in a report on Monday, June 23rd. Barclays set a $416.00 price target on HCA Healthcare and gave the stock an "overweight" rating in a report on Monday, June 2nd. Finally, Stephens upgraded HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Seven equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, HCA Healthcare has a consensus rating of "Moderate Buy" and an average target price of $395.71.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.